Home   Search   Browse   Statistics   User guide   FAQs   Post question   Download   Process data  
Search results for the GEO ID: GSE34771
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM854942
GPL570
PCNSL patient 1 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: male age: 65 years karnofsky performance status (kps): 60 therapy: HD-MTX-containing polychemotherapy outcome: dead survival time: more than 3 years Tumor tissue from male patient, 65 years old, KPS 60, HD-MTX containing polychemotherapy treated.
GSM854943
GPL570
PCNSL patient 2 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: male age: 73 years karnofsky performance status (kps): 70 therapy: HD-MTX-containing polychemotherapy outcome: dead survival time: more than 3 years Tumor tissue from male patient, 73 years old, KPS 70, HD-MTX containing polychemotherapy treated.
GSM854944
GPL570
PCNSL patient 3 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: male age: 55 years karnofsky performance status (kps): 70 therapy: HD-MTX-containing polychemotherapy outcome: dead survival time: less than 1 year Tumor tissue from male patient, 55 years old, KPS 70, HD-MTX containing polychemotherapy treated.
GSM854945
GPL570
PCNSL patient 4 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: male age: 62 years karnofsky performance status (kps): 100 outcome: dead survival time: 1-2 years Tumor tissue from male patient, 62 years old, KPS 100.
GSM854946
GPL570
PCNSL patient 5 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: female age: 71 years karnofsky performance status (kps): 80 therapy: HD-MTX-containing polychemotherapy outcome: alive survival time: more than 3 years Tumor tissue from female patient, 71 years old, KPS 80, HD-MTX containing polychemotherapy treated.
GSM854947
GPL570
PCNSL patient 6 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: female age: 63 years karnofsky performance status (kps): 70 therapy: HD-MTX-containing polychemotherapy outcome: dead survival time: 1-2 years Tumor tissue from female patient, 63 years old, KPS 70, HD-MTX containing polychemotherapy treated.
GSM854948
GPL570
PCNSL patient 7 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: male age: 70 years karnofsky performance status (kps): 70 therapy: HD-MTX-containing polychemotherapy outcome: dead survival time: 2-3 years Tumor tissue from male patient, 70 years old, KPS 70, HD-MTX containing polychemotherapy treated.
GSM854949
GPL570
PCNSL patient 8 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: female age: 70 years karnofsky performance status (kps): 100 therapy: HD-MTX-containing polychemotherapy outcome: dead survival time: 2-3 years Tumor tissue from female patient, 70 years old, KPS 100, HD-MTX containing polychemotherapy treated.
GSM854950
GPL570
PCNSL patient 9 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: female age: 66 years karnofsky performance status (kps): 60 therapy: HD-MTX-containing polychemotherapy outcome: dead survival time: more than 3 years Tumor tissue from female patient, 66 years old, KPS 60, HD-MTX containing polychemotherapy treated.
GSM854951
GPL570
PCNSL patient 10 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: male age: 68 years karnofsky performance status (kps): 100 therapy: HD-MTX-containing polychemotherapy outcome: dead survival time: less than 1 year Tumor tissue from male patient, 68 years old, KPS 100, HD-MTX containing polychemotherapy treated.
GSM854952
GPL570
PCNSL patient 11 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: male age: 69 years karnofsky performance status (kps): 50 outcome: dead survival time: more than 3 years Tumor tissue from male patient, 69 years old, KPS 50.
GSM854953
GPL570
PCNSL patient 12 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: male age: 58 years karnofsky performance status (kps): 80 therapy: HD-MTX-containing polychemotherapy outcome: alive survival time: more than 3 years Tumor tissue from male patient, 58 years old, KPS 80, HD-MTX containing polychemotherapy treated.
GSM854954
GPL570
PCNSL patient 13 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: male age: 47 years karnofsky performance status (kps): 70 outcome: dead survival time: more than 3 years Tumor tissue from male patient, 47 years old, KPS 70.
GSM854955
GPL570
PCNSL patient 14 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: female age: 68 years karnofsky performance status (kps): 90 therapy: HD-MTX-containing polychemotherapy outcome: dead survival time: more than 3 years Tumor tissue from female patient, 68 years old, KPS90 , HD-MTX containing polychemotherapy treated.
GSM854956
GPL570
PCNSL patient 15 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: female age: 59 years karnofsky performance status (kps): 70 therapy: HD-MTX-containing polychemotherapy outcome: dead survival time: 1-2 years Tumor tissue from female patient, 59 years old, KPS 70, HD-MTX containing polychemotherapy treated.
GSM854957
GPL570
PCNSL patient 16 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: male age: 74 years karnofsky performance status (kps): 70 therapy: HD-MTX chemotherapy outcome: survival survival time: more than 3 years Tumor tissue from male patient, 74 years old, KPS 70, HD-MTX chemotherapy treated.
GSM854958
GPL570
PCNSL patient 17 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: female age: 57 years karnofsky performance status (kps): 90 therapy: HD-MTX chemotherapy outcome: dead survival time: 2-3 years Tumor tissue from female patient, 57 years old, KPS 90, HD-MTX chemotherapy treated.
GSM854959
GPL570
PCNSL patient 18 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: female age: 68 years karnofsky performance status (kps): 60 therapy: HD-MTX-containing polychemotherapy outcome: dead survival time: more than 3 years Tumor tissue from female patient, 68 years old, KPS 60, HD-MTX containing polychemotherapy treated.
GSM854960
GPL570
PCNSL patient 19 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: male age: 62 years karnofsky performance status (kps): 100 therapy: HD-MTX-containing polychemotherapy outcome: dead survival time: more than 3 years Tumor tissue from male patient, 62 years old, KPS 100, HD-MTX containing polychemotherapy treated.
GSM854961
GPL570
PCNSL patient 20 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: female age: 68 years karnofsky performance status (kps): 40 therapy: HD-MTX chemotherapy outcome: survival survival time: less than 1 year Tumor tissue from female patient, 68 years old, KPS 40, HD-MTX chemotherapy treated.
GSM854962
GPL570
PCNSL patient 21 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: male age: 57 years karnofsky performance status (kps): 60 therapy: HD-MTX chemotherapy outcome: dead survival time: less than 1 year Tumor tissue from male patient, 57 years old, KPS 60, HD-MTX chemotherapy treated.
GSM854963
GPL570
PCNSL patient 22 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: male age: 63 years karnofsky performance status (kps): 50 outcome: survival survival time: less than 1 year Tumor tissue from male patient, 63 years old, KPS.50
GSM854964
GPL570
PCNSL patient 23 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: female age: 59 years karnofsky performance status (kps): 50 therapy: HD-MTX chemotherapy outcome: dead survival time: more than 3 years Tumor tissue from female patient, 59 years old, KPS 50, HD-MTX chemotherapy treated.
GSM854965
GPL570
PCNSL patient 24 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: male age: 64 years karnofsky performance status (kps): 80 therapy: HD-MTX chemotherapy outcome: survival survival time: more than 3 years Tumor tissue from male patient, 64 years old, KPS80, HD-MTX chemotherapy treated.
GSM854966
GPL570
PCNSL patient 25 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: male age: 63 years karnofsky performance status (kps): 80 therapy: HD-MTX chemotherapy outcome: dead survival time: 2-3 years Tumor tissue from male patient, 63 years old, KPS 80, HD-MTX chemotherapy treated.
GSM854967
GPL570
PCNSL patient 26 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: male age: 76 years karnofsky performance status (kps): 60 therapy: HD-MTX chemotherapy outcome: dead survival time: 1-2 years Tumor tissue from male patient, 76 years old, KPS 60, HD-MTX chemotherapy treated.
GSM854968
GPL570
PCNSL patient 27 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: male age: 44 years karnofsky performance status (kps): 50 therapy: HD-MTX chemotherapy outcome: dead survival time: 2-3 years Tumor tissue from male patient, 44 years old, KPS 50, HD-MTX chemotherapy treated.
GSM854969
GPL570
PCNSL patient 28 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: female age: 68 years karnofsky performance status (kps): 50 therapy: HD-MTX chemotherapy outcome: dead survival time: 2-3 years Tumor tissue from female patient, 68 years old, KPS 50, HD-MTX chemotherapy treated.
GSM854970
GPL570
PCNSL patient 29 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: male age: 50 years karnofsky performance status (kps): 70 therapy: HD-MTX chemotherapy outcome: alive survival time: more than 3 years Tumor tissue from male patient, 50 years old, KPS 70, HD-MTX chemotherapy treated.
GSM854971
GPL570
PCNSL patient 30 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: female age: 71 years karnofsky performance status (kps): 40 therapy: HD-MTX chemotherapy outcome: dead survival time: 1-2 years Tumor tissue from female patient, 71 years old, KPS 40, HD-MTX chemotherapy treated.
GSM854972
GPL570
PCNSL patient 31 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: female age: 72 years karnofsky performance status (kps): 70 therapy: HD-MTX chemotherapy outcome: alive survival time: more than 3 years Tumor tissue from female patient, 72 years old, KPS 70, HD-MTX chemotherapy treated.
GSM854973
GPL570
PCNSL patient 32 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: male age: 64 years karnofsky performance status (kps): 70 therapy: HD-MTX chemotherapy outcome: alive survival time: more than 3 years Tumor tissue from male patient, 64 years old, KPS 70, HD-MTX chemotherapy treated.
GSM854974
GPL570
PCNSL patient 33 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: female age: 67 years karnofsky performance status (kps): 50 therapy: HD-MTX chemotherapy outcome: alive survival time: 1-2 years Tumor tissue from female patient, 67 years old, KPS 50, HD-MTX chemotherapy treated.
GSM854975
GPL570
PCNSL patient 34 Human brain tumor tissue from PCNSL patient tissue: brain tumor disease state: primary central nervous system lymphoma (PCNSL) gender: female age: 68 years karnofsky performance status (kps): 60 therapy: HD-MTX chemotherapy outcome: alive survival time: less than 1 year Tumor tissue from female patient, 68 years old, KPS 60, HD-MTX chemotherapy treated.
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes